Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease.

about

miR-203 Inhibits Alcohol-Induced Hepatic Steatosis by Targeting Lipin1.

P2860

Q52579260-DC6894ED-D031-4EE7-A58B-0D51AAA00AFD

P2860

Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease.

Item

http://www.wikidata.org/entity/Q47595575

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Inhibition of MD2-dependent in ...... alcoholic fatty liver disease.

@en

Inhibition of MD2-dependent in ...... alcoholic fatty liver disease.

@nl

type

Item

label

Inhibition of MD2-dependent in ...... alcoholic fatty liver disease.

@en

Inhibition of MD2-dependent in ...... alcoholic fatty liver disease.

@nl

prefLabel

Inhibition of MD2-dependent in ...... alcoholic fatty liver disease.

@en

Inhibition of MD2-dependent in ...... alcoholic fatty liver disease.

@nl

P1476

Inhibition of MD2-dependent in ...... -alcoholic fatty liver disease

@en

P2093

Beibei Wu

http://www.w3.org/2001/XMLSchema#string

Chao Chen

http://www.w3.org/2001/XMLSchema#string

Hailing Zhang

http://www.w3.org/2001/XMLSchema#string

Li Wang

http://www.w3.org/2001/XMLSchema#string

Mengwei Hu

http://www.w3.org/2001/XMLSchema#string

Shilong Ying

http://www.w3.org/2001/XMLSchema#string

Weixin Li

http://www.w3.org/2001/XMLSchema#string

Xiangting Ge

http://www.w3.org/2001/XMLSchema#string

Xiaoou Shan

http://www.w3.org/2001/XMLSchema#string

Yali Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame

MAPK kinases as nucleo-cytoplasmic shuttles for PPARgamma

Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.

Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ.

Human fatty liver disease: old questions and new insights

Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.

HMGB1 is a therapeutic target for sterile inflammation and infection.

Hepatic TLR4 signaling in obese NAFLD

P304

936-947

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCMM.13395

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guang Liang

P577

2017-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29077272

http://www.w3.org/2001/XMLSchema#string

P932

5783870

http://www.w3.org/2001/XMLSchema#string

Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease.

about

P2860

P2860

Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932